The global multimodal imaging market is expected to grow at a CAGR of 5.3% from 2018 to reach $1.6 billion by 2024.
The multimodal imaging systems play an important role in addressing the issues for the treatment of chronically ill and aged population. The multimodal imaging is used in early detection of disease in areas such as oncology, neurology, cardiology, urology, and more. Multimodal imaging is widely used in the detection of tumor lesions for precise delivery of therapy.
The growth of global multimodal imaging market is driven by rapidly increasing geriatric population with prevalence of chronic illness, technological advancements in the development of imaging systems, and increasing drug discovery programs. However, high cost of instruments & imaging facility establishment and paucity of skilled healthcare professionals hinders the growth of this market. On the other hand, significant opportunities from developing economies are likely to offer high growth opportunities.
According to the United Nations, in 2017, population aged 60 years or over reached 962 million, which is expected to increase to 2.1 billion by 2050. Also, the number of people aged 80 years or above is projected to increase threefold between 2017 and 2050, rising from 137 million to 425 million. Also, according to Canadian Cancer Society, in Canada, it is estimated that by 2030, new cancer cases are expected to increase by about 40%. It is projected that by 2030, ~77,000 people will be diagnosed with cancer each year.
Here are the top 10 companies in Multimodal Imaging Systems –
Founded in 1847 and headquartered at Munich, Germany; Siemens AG is a technology company engaged in the field of electrification, automation and digitalization. The company provides multimodal imaging systems through its subsidiary Siemens Healthineers. The Siemens Healthineers was organized into six business areas: Diagnostic Imaging, Laboratory Diagnostics, Advanced Therapies, Ultrasound, Point of Care Diagnostics, and Services. The company provides multimodal imaging systems under diagnostic imaging business area.
With its subsidiaries and strong network of distribution, the company has its presence in various regions such as North America, Europe, Asia- Pacific, Latin America, and Middle East & Africa. The major subsidiaries of the company include Siemens Healthineers (Germany), Siemens Canada Limited (Canada), Siemens AB (Sweden), and more.
Incorporated in 1892 and headquartered at Chicago, Illinois, the U.S.; GE Healthcare, a subsidiary of General Electric (GE), offers medical imaging, diagnostics, therapeutics, biopharmaceutical manufacturing, patient monitoring, and drug discovery products. The company operates through three business segments, namely, Healthcare Systems, Life Sciences, and Healthcare Digital. The company’s customers include medical institutions, hospitals, research institutes, pharmaceutical, biotechnology companies, and life science research centers across the world. The company provides multimodal imaging systems under healthcare systems business segment.
With its subsidiaries and strong network of distribution, the company has its presence in various regions such as North America, Europe, Asia- Pacific, Latin America, and Middle East & Africa.
A report into the projected growth of the current Multimodal Imaging Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2024, it’s expected to have grown at a CAGR of 5.3%, reaching over $ 1500 million.
Koninklijke Philips N.V.
Founded in 1891 and is headquartered at Amsterdam, the Netherlands; Koninklijke Philips N.V. operates as a health technology company worldwide. The company operates through five business segments namely Personnel Health, Lighting, Diagnosis & Treatment, Connected care & Health informatics, and Healthtech Other. The company offers imaging systems that improve outcomes, lower the cost of care delivery and enhance patient experiences by enabling right diagnosis and treatment. The company provides multimodal imaging systems under diagnosis & treatment business segment.
With more than 50 subsidiaries and strong network of distribution, the company has its presence across the world including North America, Europe, Asia- Pacific, Latin America, and Middle East & Africa.
Founded in 1960 and headquartered at Massachusetts, U.S.; Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical & diagnostic solutions to explore science at microscopic, molecular, and cellular levels. The company operates through two business segments namely Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). The company provides multimodal imaging systems under Bruker Scientific Instruments business segment. Within BSI, the company is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. Bruker BioSpin manufactures and sells single and multiple modality systems using MRI, PET, SPECT, CT and MPI.
With its subsidiaries and strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The subsidiaries of the company include Bruker BioSpin GmbH (Germany), Bruker Española S.A. (Spain), Hysitron, Inc. (U.S.), Bruker India Scientific Pvt Ltd. (India), and others.
Founded in 1937 and headquartered at Tokyo, Japan; Canon Inc. manufactures imaging and optical products including cameras, camcorders, photocopiers, steppers, computer printers, and medical equipment. The company operates through four business segments namely office; imaging system; medical system; industry; and others. The company acquired Toshiba Medical Systems Corporation (U.S.) in December 2016, which established the medical systems business segment in 2017. The company provides multimodal imaging systems through its medical systems business segment. The Canon Medical Systems develops and manufactures diagnostic imaging systems including CT, MRI, PET/CT, ultrasound, X-ray systems, and clinical laboratory systems.
With its subsidiaries and network of distribution, the company has presence in Japan, North America, South America, Europe, Africa/Middle East, Asia, and Oceania. The major subsidiaries of the company include Canon Medical Systems Corporation (Japan), Canon Medical Systems Korea Co., Ltd. (Korea), Canon U.S.A. Inc. (U.S.), and more.
Founded in 1990 and headquartered at Budapest, Hungary; Mediso Ltd. is a manufacturer of nuclear medicine and modern hybrid imaging techniques to the health care and medical research institutions. The company offers triple-modality SPECT-CT-PET clinical systems, SPECT/CT, and PET/CT equipment, as well as various single or multi-detector SPECT products.
With its subsidiaries and strong network of distribution, the company has its presence across U.S., Germany, Poland, and Hungary. The major subsidiaries of the company are Mediso Polska (Poland) and Mediso GmbH (Germany).
Founded in 2006 and headquartered at Utrecht, the Netherlands; MILabs B.V. is engaged in the development of preclinical PET, SPECT, CT and optical imaging systems and human SPECT scanners. The company also offers imaging systems for SPECT, PET, CT, autoradiography as well as bioluminescence, fluorescence and cherenkov imaging applications.
With its strong network of distribution, the company provides products in more than 65 countries and has strong presence in North America, Europe, Asia-Pacific, and Middle East.
MR Solutions Ltd.
Founded in 1985 and headquartered at Guildford, U.K.; MR Solutions Ltd. is a developer and manufacturer of commercial, superconducting, cryogen-free (dry magnet), preclinical benchtop MRI systems. The company also accessorizes its preclinical MRI scanners with PET and SPECT modules for both sequential and simultaneous acquisition of MR data.
With its strong network of distribution, the company has its presence across North America, Asia, and U.K.
Northridge Tri-Modality Imaging, Inc.
Founded in 2013 and headquartered at California, the U.S.; Northridge Tri-Modality Imaging, Inc. is a provider of molecular imaging solutions for pre-clinical procedures. The company design, manufacture and support preclinical imaging systems in universities, pharmaceutical companies and research centres around the world. The company also offers advice from applications scientists to assist in setting up of preclinical lab and designing application protocols to post-processing and image analysis.
With its strong network of distributors, the company has its presence in across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1947 and headquartered at Waltham, Massachusetts, U.S.; PerkinElmer, Inc. is a provider of products, services, and solutions for diagnostics, food, environment, industrial, life science research, and laboratory services market. The company operates through two business segments namely Discovery & Analytical Solutions and Diagnostics. The company provides instruments, reagents, analytical technologies, assay platforms, software, pre-clinical imaging system, and more to hospitals, medical labs, clinicians, and medical research professionals. The company provides multimodal imaging systems in Discovery & Analytical Solutions business segment.
With its subsidiaries and strong network of distributors, the company has its presence in more than 150 countries across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The company provides various products through its subsidiaries such as Caliper Life Sciences, PerkinElmer Ltd., PerkinElmer Health Sciences, Inc., and more.
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on this industry with Research PDF
Authoritative Research on the Multimodal Imaging Market – Global Opportunity Analysis and Industry Forecast (2018-2024)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
- Impact of Covid 19
Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more:https://www.meticulousresearch.com/download-sample-report/cp_id=4876